Na di klinik dɛn we de mɛn di skin, di biuti salon ɛn di soshal midia shɔp dɛn kin sɛl di injɛkshɔn dɛn we de mek di skin wayt. Insay Indonishia dɛn kin kɔl dɛn suntik putih ɔ suntikan pemutihan ; ɔdasay dɛn kin makɛt dɛn as glutathione drip, vaytamɛn C shot ɔ 'brightening boosters'. Dɛn injɛkshɔn ya sef, udat de rigul dɛn, ɛn aw klinik ɔ pɔsin we sik go no tru tru prɔdak frɔm fek?
Yu tink se Injɛkshɔn fɔ Wayt di Skin Sef? Di Shɔt Ansa
I dipen pan tri tin: wetin dɛn de injɛkt, aw dɛn de injɛkt am ɛn usay di prɔdak kɔmɔt. Wan prodak we dɛn dɔn rɛjista, we dɛn kin yuz fɔ wan aprɔv ɔ pruf-bɛs indikɛshɔn we kwalifay prɛktishɔn na steril sɛtin, kin kɛr wan rili difrɛn risk prɔfayl frɔm wan vayl we nɔ rɛjista we dɛn bay ɔnlayn ɛn gi as intravenɔs drip na salon.
Tu tru tin dɛn de mek di tɔk. Fɔs, di US FDA ɛn di Filipin FDA ɔl tu tɔk se dɛn nɔ gri fɔ ɛni injɛkt prodak fɔ mek di skin wayt ɔ fɔ mek i layt. Sɛkɔn, bɔku tɛm di big big prɔblɛm dɛn nɔ kin kɔmɔt frɔm di tin we dɛn mek insɛf bɔt na di prɔdak dɛn we dɛn nɔ no ɛn di we aw dɛn kin injɛkshɔn we nɔ sef. No injɛkshɔn nɔ go ebul fɔ chenj di natura skin kɔlɔ fɔ ɔltɛm, wan pɔynt we wi atikul de tɔk bɔt di injεkshכn dεm we de mek di skin wayt fכ כ ltεm de εksplen mכr ditayli.
Wetin Na di Risk dɛm fɔ Wait Injɛkshɔn?
Risk dɛn we kin kɔmɔt frɔm di prɔdak insɛf
Di US FDA dɔn wɔn se di tin dɛn we dɛn kin yuz fɔ mek di skin wayt we dɛn kin injɛkt we dɛn kin sɛl na di Intanɛt ɛn na spa dɛn nɔ kin sef ɛn nɔ kin wok ɛn dɛn kin gɛt tin dɛn we kin ambɔg pɔsin ɔ tin dɛn we dɛn nɔ no. As wan FDA fama tɔk am, di wan dɛn we de yuz am de 'essentially inject an unknown substance' we dɛn nɔ no wetin de insay ɔ aw dɛn mek am. di FDA se dεn prכdak ya kin gεt glutathione, vaytam in C, kolagen εn ivin mכtalman plasεnta.
Risk frɔm di injɛkshɔn prosidur
Ɛni injɛkshɔn de brok di tin we de ambɔg di skin. Di FDA notis se di injɛkshɔn we nɔ fayn ɔ we nɔ sef kin mek pɔsin gɛt sik, mek pɔsin gɛt infɛkshɔn ɛn i kin mek pɔsin gɛt siriɔs injury. Di Filipin FDA tɔk mɔ bɔt di risk fɔ transmit HIV ɛn epataytis B ɛn C, we kin rili wɔri we pɔsin we nɔto dɔktɔ gi di tritmɛnt ɔ di fasiliti nɔ steril.
Risk dεm we spεsifi k to hεy-doz IV drip dεm
Mɔs pan di sef wɔnin dɛn kin gɛt fɔ du wit aw fɔ yuz am insay di bɛlɛ. Di Filipin FDA list di poshubul toxik ifekt dɛm we injektabl glutathione gɛt pan di liva, kidni ɛn nervɔs sistɛm, plus di posisibul fɔ Stevens-Johnson syndrome, we na wan bad bad riakshɔn na di skin. Fɔ IV vaytamɛn C, i de wɔn se kidni ston kin fɔm if di urine gɛt asid ɛn big dos dɔn mek dɛn gɛt ɛmodayalis pan pipul dɛn we nɔ gɛt G6PD. Wan US sɔv we dɛn du pan IV vaytamɛn C yus bin fɛn sayd ifɛkt pan 101 pan 9,328 pasɛnt dɛn, bɔku pan dɛn na smɔl smɔl, bɔt dɛn kɔnfyus kɔmplikeshɔn dɛn we dɛn no pan pipul dɛn we gɛt kidni prɔblɛm ɔ G6PD dɛfisiɛns (Padayatty et al., 2010). Skrin impɔtant.
Di ifɛkt dɛn we dɛn nɔ no bɔt fɔ lɔng tɛm
Wan rivyu we dɛn bin du insay di Sawt Afrika Mɛdikal Jɔnal insay 2016 nɔ bin si ɛni stɔdi we dɛn dɔn pablish bɔt IV glutathione fɔ mek di skin layt ɛn dɛn nɔ si ɛni data bɔt aw i sef fɔ yuz am fɔ lɔng tɛm. di awta dεm rayz wan tiori kכnsεn bak: biכs glutathione de shift melanin prodakshכn frכm brawn to rεd pigmεnt, i kin inkrεs di risk fכ san-indyus skin kεnsar pan pipul dεm we dεn bin protεkt bifo wit dak pigmεnt (Davids et al., 2016). Di Filipin FDA de tɔk bɔt di sem tiori kɔnsyans. Dis na opin kwɛstyɔn dɛn, nɔto bad tin dɛn we dɛn dɔn pruv.
Aw di Rigyulatɔ dɛn De Si di Injɛkshɔn dɛn we de mek di skin wayt
Amɛrika
Di FDA se dɛn nɔ dɔn gri fɔ ɛni mɛrɛsin we dɛn kin injɛkt fɔ mek di skin wayt ɔ layt ɛn dɛn de trit dɛn kayn prɔdak dɛn de lɛk nyu mɛrɛsin we dɛn nɔ gri fɔ. Insay 2014, di US Mashal dɛn bin tek di waytning kit dɛn we dɛn nɔ bin gri fɔ sɛl we wan kɔmni na Nyu Jɛsi bin sɛl we di FDA bin aks fɔ am, ɛn insay 2017, wan fedaral jɔj bin tɛl di kɔmni fɔ stɔp fɔ sɛl ɛn kɔl sɔm prɔdak dɛn bak.
Filipins
Insay in 2019 advisory on the unsafe use of glutathione as a skin lightening agent , di Filipin FDA bin tɔk se dɛn nɔ gri fɔ ɛni injɛkshɔn prodak fɔ mek di skin layt ɛn dɛn dɔn gri fɔ injɛkt glutathione nɔmɔ as adjɔnt tritmɛnt insay cisplatin kemotɛrapi. I advays di pipul dɛn fɔ go to dɔktɔ dɛn we gɛt di bɔd sɛtifiket fɔ mɛn dɛn bɔdi ɛn fɔ avɔyd fɔ bay tin dɛn we dɛn kin injɛkt na di Intanɛt.
Indonishia
Indonishia in it ɛn drɔg ɔtoriti, BPOM, klas vaytamɛn C injɛkshɔn as prɛskrishɔn drɔg fɔ trit vaytamɛn C dɛfisiɛns, akɔdin to wan stɔdi we BPOM wokman dɛn du (Rastika et al., 2022). Fɔ ɔral glutathione suplimɛnt, BPOM de alaw maksimam 600 mg fɔ wan de ɛn i nɔ de alaw fɔ mek dɛn prɔmot di prɔdak dɛn as tin dɛn we de mek di skin wayt.
Ɔlsay ɔdasay
Di lɔ dɛn bɔt aw fɔ rɛjista prɔdak ɛn udat kin injɛkt difrɛn bay kɔntri. Bifo yu bay ɔ gi ɛni injɛkshɔn we de mek pɔsin brayt, chɛk aw yu nashɔnal rɛgyulatɔ de klas di prɔdak ɛn di we aw dɛn want fɔ yuz am.
Di Kɔmpiti Prɔblɛm
Di ay dimand, ɔnlayn sɛl ɛn krɔs-bɔda shiping de mek waytin injɛktabl na target fɔ falsifikɛshɔn. Di Wɔl Ɛlth Ɔganayzeshɔn in fact sheet on substandard and falsified medikal prodakt dεm εstimat se at le 1 pan 10 mεdikal dεm na low εn midul income kontri dεm na substandard כ falsified εn i notis se bכku tεm dεn kin sכl dεn kayn prכdak dεm na כnlayn כ na infכmal makit dεm. Di lay lay prɔdak dɛn kin mek pipul dɛn no udat dɛn bi, di tin dɛn we dɛn mek ɔ usay dɛn kɔmɔt bay wilful.
Di tin dɛn we dɛn kin mek fɔ wayt pɔsin nɔto ɛksɛpshɔn. We BPOM risach pipul dɛn bay 4 vaytamɛn C injɛkshɔn brand dɛn we nɔ rɛjista frɔm wan onlayn makit ɛn tɛst dɛn, tri nɔ mit di vaytamɛn C kɔntinyu we dɛn rayt na di lɛbl; wan bin gɛt 12.8% nɔmɔ pan di mɔni we dɛn bin de tɔk bɔt. Di sem stכdi fכnshכn se dεn injεkshכn ya we dεn de sכl tru i-kכmishכn, biuti klinik dεm εn biuti εgzibishכn, εn et pan nayn klinik dεm we de gi waytin injεkshכn dεm nכ go kכl di brand we dεn yuz (Rastika et al., 2022). Insay 2025, BPOM bin ripɔt se lab tɛst pan sɛmpul dɛn fɔ wan glutathione waytin suplimɛnt we nɔ rɛjista nɔ bin si ɛni L-glutathione atɔl, ɛn se sɛmpul dɛn difrɛn pan saiz, dizayn, logo ɛn ɔlogram. Dat kes bin gɛt fɔ du wit kapsul dɛn we dɛn kin tek bay mɔt, nɔto injɛkshɔn, bɔt i de sho aw fa lɛbl dɛn kin drɛf frɔm di tin dɛn we de insay.
Aw fɔ Spot Fake Skin Whitening Injection: Wan Chɛklist
No wan chɛk nɔ de we de pruv se wan prɔdak na tru tru tin, bɔt ɛni rɛd flag na rizin fɔ chɛk.
Wetin fɔ chɛk
Wetin tru tru prɔdak fɔ sho
Rɛd flag
Fɔ rɛjista
Wan rɛjista ɔ laysens nɔmba we yu kin fɛn na yu nashɔnal rɛgyulatɔ in database fɔ da ɛksaktɔl prɔdak de
Nɔ nɔmba, nɔmba we nɔ mach, ɔ 'rɛjista na ɔda kɔntri' klem nɔmɔ
Lebul ɛn langwej
Ful ingridiɛnt list, trɛnk, volyum, di we aw dɛn de yuz am, batch nɔmba, di de we dɛn mek ɛn di tɛm we dɛn fɔ dɔn, ɛn lɛbul insay langwej we dɛn nid na yu makit
Di tin dɛn we dɛn yuz ɔ di de dɛn we dɛn nɔ rayt, di mistek we dɛn spɛl am, ɔ we dɛn rayt di lɛbl dɛn nɔmɔ insay fɔrina langwej
Pak ɛn sil dɛn
Kɔnsistɛns print kwaliti, intakt flip-ɔf kap ɛn tamper-evident sil, ɛn di sem dizayn akɔdin to batch dɛn
Kap dɛn we lɔs ɔ kruk, sil dɛn we brok, ɔ difrɛns pan saiz, logo ɔ ɔlogram bitwin bɔks dɛn
Di tin dɛn we de insay
Sɔlv ɔ paoda we de mach di prɔdak diskrɔpshɔn
Klaud likwid, patikyula ɔ diskɔlɔreshɔn we di wan we mek am nɔ tɔk bɔt
Klɛm dɛn
Modest, spesifik klem dɛn we gri wit lokal lɔ dɛn
Prɔmis fɔ wayt pɔsin fɔ ɔltɛm, 'ful-bɔdi' laytin ɔ fɔ mɛn sik dɛn we nɔ gɛt natin fɔ du wit am
Usay i kɔmɔt
Manufacturer ɔ authorized distributor we kin gi dɔkyumentri ɛn batch traceability
Soshal midia sɛlda dɛm, anonymous marketplace shop dɛm ɔ prayz dɛm fa fawe pas di usual range
Udat de injekt
Wan kwalifay, laysens prɛktishɔn na klin klinik sɛtin
Hom visit, salon 'drip parties' ɔ wan prɔvayda we nɔ go gi di prɔdak in nem
BPOM in yon kɔshɔma sɔtkat na 'Cek KLIK': chɛk di pak ( Kemasan ), lɛbl ( Lebul ), makɛt ɔtorizeshɔn ( Izin edar ) ɛn di de we i fɔ dɔn ( Kedaluwarsa ) bifo yu bay.
Kwɛstyɔn dɛn we di wan dɛn we sik fɔ aks bifo dɛn trit dɛn
Wetin rili de insay di injɛkshɔn, ɛn a kin si di ɔrijinal bɔks ɛn di vayl?
Dɛn dɔn rɛjista dis prɔdak fɔ dis yus na wi kɔntri?
Dɛn kin injekt am na di skin (mɛsotɛrapi) ɔ dɛn kin gi am as IV drip?
Udat go du di tritmɛnt, ɛn wetin na dɛn kwalifayeshɔn?
A nid ɛni tɛst fɔs, lɛk G6PD ɔ kidni skrinin fɔ ay doz vaytamɛn C?
Us rizulyt dɛn kin rili apin, ɛn wetin a fɔ du if a gɛt wan riakshɔn?
Fɔ klinik ɛn distribyushɔn, fek vayl na prɔblɛm wit di pɔsin in sef, ligal ɛn gudnem. Bay dairekt frɔm di wan dɛn we de mek ɔ di wan dɛn we gɛt rayt fɔ sheb di tin dɛn, kip di batch nɔmba dɛn na fayl fɔ ɛni tritmɛnt, kɔnfɔm se di lɛbl ɛn rɛjista fit yu makit, ɛn kwarantin ɛni stok we gɛt sil we dɔn pwɛl ɔ we nɔ gɛt wanwɔd.
AOMA de saplae braytning mesotherapy solushɔn, inklud TXA, vaytamɛn C ɛn kɔmbayn fɔmula, to laysens klinik ɛn distribyushɔn, wit batch-traceable stok ɛn OEM prodakshɔn. Brayz di AOMA skin waytin injεkshכn rεnj . Di MOQ stat frɔm 200 yunit fɔ ɔl tu di stok ɛn OEM ɔda dɛn. Stock oda ship insaid 24 awa, en OEM lida taim na 2–3 wiks afta artwok, fomula en pak ditel dem konfam. AOMA gɛt CE, ISO 13485, GMP ɛn FDA sɛtifiket dɛn.
FAQ we dɛn kin aks
Yu tink se injɛkshɔn dɛn we de mek yu skin wayt nɔ bad?
Di US FDA ɔ di Filipin FDA nɔ gri fɔ mek dɛn wayt di skin. Risk dɛn dipen pan di prɔdak, di rod ɛn di injɛkta. Prodak we nɔ rɛjista ɛn IV drip we dɛn gi ausayd mɛdikal sɛtin kin kɛr di big big risk.
Yu tink se dɛn dɔn gri fɔ mek yu gɛt IV glutathione fɔ mek yu skin wayt?
Nɔ, di Filipin FDA gri fɔ gi glutathione we dɛn kin injɛkt jɔs as adjɔnt fɔ cisplatin kemotɛrapi, ɛn di US FDA nɔ gri fɔ ɛni mɛrɛsin we dɛn kin injɛkt fɔ mek di skin layt.
Aw a go no if injɛkshɔn we de mek pɔsin wayt na fek?
Chek se di rɛjista nɔmba de mach yu rɛgyulatɔ in database, di lɛbl dɔn kɔmplit, di sil dɛn nɔ pwɛl, di pak nɔ de chenj ɛn di pɔsin we de sɛl kin rayt di sɔs. Prays we nɔ kɔmɔn ɛn pipul dɛn we nɔ no dɛn nem fɔ sɛl na di Intanɛt na sayn dɛn we de wɔn pipul dɛn.
Na 'suntik putih' ligal na Indonishia?
BPOM de klas vaytamɛn C injɛkshɔn as prɛskrishɔn drɔg, ɛn dɛn dɔn si se dɛn de sɛl vaytamɛn C injɛkshɔn dɛn we nɔ rɛjista na di intanɛt, na biuti ɛgzibishin ɛn tru klinik dɛn. Aksept ɔl di prɔdak dɛn we dɛn dɔn rɛjista we di mɛdikal pɔshɔnal dɛn we gɛt rayt fɔ gi.
Wetin a fɔ du if a riak bad we dɛn gi mi injɛkshɔn we de mek a wayt?
Sik mɛdikal kia kwik kwik wan ɛn ripɔt di riakshɔn to yu nashɔnal rɛgyulatɔ. Kip di prodak bɔks ɔ batch nɔmba if yu ebul.
Rifrɛns dɛn
Di US Fɔd ɛn Drug Administreshɔn. Kɔnsuma ɔpdet pan injɛktabl skin waytning prodakt (Chaini-langwej edishɔn; ɔpdet Sɛptɛmba 26, 2017). https://www.fda.gov/kɔnsuma dɛn/kɔnsuma-ɔpdet/ninyinglejieyouguanjifumeibaizhushechanpindexinxi
Fɔd ɛn Drug Administreshɔn Filipins. FDA Advayz Nɔmba 2019-182: Yuz glutathione we nɔ sef as ejen fɔ layt di skin. 2019. https://www.fda.gov.ph/fda-advayz-nɔ-2019-182-nɔ-sef-yuz-ɔf-glutathione-as-skin-laytin-ejɛnt/
Di Wɔl Ɛlth Ɔganayzeshɔn. Di mɛrɛsin dɛn we nɔ fayn ɛn we nɔto lay lay mɛrɛsin. Fact sheet we dɛn kin rayt. https://www.who.int/nyus-rum/fakt-shit/ditel/sɔbstandad-ɛn-falsified-mɛdikal-prɔdakt dɛn
Rastika DGB, Triwinanti N, Salaffudin M. G., ɛn ɔda pipul dɛn. Peredaran vaytamɛn C injeksi ilegal di Indonishia [Sɛkyushɔn fɔ ilɛgal vaytamɛn C injɛkshɔn na Indonishia]. Eruditio we dɛn kɔl . 2022;2(2):13–21. doi: 10.54384/ɛrudishɔn.v2i2.109
Badan pengawas obat dan makanan (BPOM) bin de wok. Siaran Pers HM.01.1.2.08.25.146: Waspada produk Dɔktɔ LSW, suplimen kesehatan ilɛgal dengan klaim pemutih kulit. 21 Ɔgɔst 2025. https://www.pom.go.id/siaran-pers/waspada-produk-dr-lsw-suplemen-kesehatan-ilegal-dengan-klaim-pemutih-kulit
Davids L. M., Van Wyk J. C., Khumalo N. P., ɛn ɔda pipul dɛn. Intravenɔs glutathione fɔ mek di skin layt: nɔ gɛt bɛtɛ sefty data. S Afr Med J . 2016;106(8):782-786. PMID: 27499402, ɛn di ɔda wan dɛn.
Padayatty SJ, Sun A. Y., Chen Q, ɛn ɔda pipul dɛn. Vitamin C: we kɔmplimɛnt ɛn ɔda mɛrɛsin prɛktishɔn dɛn kin yuz insay di bɛlɛ ɛn di bad tin dɛn we kin apin to am. PLoS Wan . 2010;5(7):e11414. PMID: 20628650, ɛn di ɔda wan dɛn.
Dis atikul na fɔ tich pipul dɛn nɔmɔ ɛn nɔto dɔktɔ ɔ lɔ advays. Di tritmɛnt dɛn we dɛn kin injɛkt fɔ asɛs ɛn du bay kwalifay prɛktishɔn dɛn we de yuz prɔdak dɛn we dɛn rɛjista in layn wit di lokal rigyuleshɔn dɛn.
Dr. Emily Carter (MD, Fellow of the American Academy of Dermatology) na bɔd-sɛtifiket kɔsmɛtik sajin na Nyu Yɔk Siti wit pas 9 ia spɛshal ɛkspiriɛns pan hyaluronic acid filers, akni ska tritmɛnt, ɛn minimally invasive facial contouring. Dɛn no am mɔ fɔ in ɛkspɛriɛns pan advans injɛkshɔn tritmɛnt dɛn we de mek di akni ska dɛn layt fayn fayn wan, mek di skin wɛl, ɛn mek di skin smol bak tru di injɛkshɔn we dɛn dɔn tɔk bɔt fɔ mek di skin ripɛnt ɛn di tɛknik dɛn we dɛn de yuz fɔ mek di skin go bifo.
